Biodegradable polymer stents vs second generation drug eluting stents: A meta-analysis and systematic review of randomized controlled trials

Table 1 Summary of included trials

Ref.	Trial acronym	Yr	BD-DES type	PP-DES type	Total patients	BD-DES patients	PP-DES patients
Natsuaki et al[8]	NEXT	2013	Biolimus	Everolimus	3235	1617	1618
Smits et al[9]	COMPARE 2	2013	Biolimus	Everolimus	2707	1795	912
Gao et al[10]	TARGET 1	2013	Sirolmus	Everolimus	458	227	231
Byrne et al[11]	ISAR-TEST 4	2011	Sirolimus	Everolimus	2603	652	1304
Xu et al[12]		2011	Sirolimus	Zotarolimus	324	168	156
Separham et al[13]		2011	Biolimus	Everolimus	200	100	100
Meredith et al[14]	EVOLVE	2012	Biolimus	Everolimus	192	98	94
Pilgrim et al[15]	BIOSCIENCE	2014	Sirolimus	Everolimus	2119	1063	1056
Serruys et al[7]	ABSORB 2	2014	Everolimus	Everolimus	501	335	166
Lee et al[16]		2014	Biolimus	Everolimus	500	245	255
Windecker et al[17]	BIOFLOW 2	2014	Sirolimus	Everolimus	452	298	154

BMS: Bare metal stents; PP-DES: Permanent polymer drug eluting stents; BD-DES: Biodegradable polymer drug eluting stents.